Thomas Tu - Feb 28, 2022 Form 4 Insider Report for Inari Medical, Inc. (NARI)

Role
Chief Medical Officer
Signature
/s/ Angela Ahmad, attorney-in-fact for Thomas Tu
Stock symbol
NARI
Transactions as of
Feb 28, 2022
Transactions value $
-$360,063
Form type
4
Date filed
3/2/2022, 05:24 PM
Previous filing
Feb 22, 2022
Next filing
Mar 30, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Options Exercise $1.82K +4K +5.11% $0.46* 82.3K Feb 28, 2022 Direct F1
transaction NARI Common Stock Sale -$180K -2K -2.43% $90.03 80.3K Feb 28, 2022 Direct F1, F2
transaction NARI Common Stock Sale -$180K -2K -2.49% $90.00 78.3K Feb 28, 2022 Direct F1
transaction NARI Common Stock Options Exercise $0.91 +2 +0% $0.46* 78.3K Mar 1, 2022 Direct F1
transaction NARI Common Stock Sale -$180 -2 0% $90.00 78.3K Mar 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NARI Stock Option Options Exercise -$1.83K -4K -1.94% $0.46* 202K Feb 28, 2022 Common Stock 4K $0.46 Direct F1, F3
transaction NARI Stock Option Options Exercise $0 -2 0% $0.05* 202K Mar 1, 2022 Common Stock 2 $0.46 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2021.
F2 This transaction was executed in multiple trades at prices ranging from $90.00. to $90.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 Option vested with respected with 25% of the underline shares on April 30, 2020 and vest with respect to the remaining shares in 36 equal monthly installment there after.